# FDA Inspection 1021713 - South Texas Blood & Tissue Center - June 15, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/south-texas-blood-tissue-center/f7dbc4ba-29c9-45bb-b57a-c3f4da316c9c/
Source feed: FDA_Inspections

> FDA Inspection 1021713 for South Texas Blood & Tissue Center on June 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021713
- Company Name: South Texas Blood & Tissue Center
- Inspection Date: 2017-06-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1279560 - 2025-08-14](https://www.globalkeysolutions.net/api/records/fda_inspections/south-texas-blood-tissue-center/eb0b438b-63e2-4a2c-862f-51cdae99b320/)
- [FDA Inspection 1279560 - 2025-08-14](https://www.globalkeysolutions.net/api/records/fda_inspections/south-texas-blood-tissue-center/8e0d7857-853d-4436-9291-9528f3073943/)
- [FDA Inspection 1172990 - 2022-06-09](https://www.globalkeysolutions.net/api/records/fda_inspections/south-texas-blood-tissue-center/522679bf-3e12-42e5-9053-63b312cedb3e/)
- [FDA Inspection 1172990 - 2022-06-09](https://www.globalkeysolutions.net/api/records/fda_inspections/south-texas-blood-tissue-center/1a5b5ca5-6175-4c1d-a80b-9f23645ef37b/)
- [FDA Inspection 1172990 - 2022-06-09](https://www.globalkeysolutions.net/api/records/fda_inspections/south-texas-blood-tissue-center/23534f60-e9d9-4c33-a4c5-866e619ae006/)

Company: https://www.globalkeysolutions.net/companies/south-texas-blood-tissue-center/f300c449-57f5-4e4b-b1b9-1ed80dc00c7e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d